Keith D Aaronson
Overview
Explore the profile of Keith D Aaronson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
183
Citations
3857
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang H, Gonzalez R, Nallamothu B, Aaronson K, Ward K, Hero 3rd A, et al.
Proceedings (IEEE Int Conf Bioinformatics Biomed)
. 2025 Feb;
2023:3226-3233.
PMID: 39949328
Disease risk prediction models play an important role in preventing disease developments in modern healthcare. However, the lack of focus on high-risk patients has hindered the large-scale practical application of...
2.
Mathis M, Ghadimi K, Benner A, Jewell E, Janda A, Joo H, et al.
Br J Anaesth
. 2024 Oct;
134(1):32-44.
PMID: 39389834
Background: The accurate diagnosis of heart failure (HF) before major noncardiac surgery is frequently challenging. The impact of diagnostic accuracy for HF on intraoperative practice patterns and clinical outcomes remains...
3.
Lund L, James S, DeVore A, Anstrom K, Fudim M, Aaronson K, et al.
Eur J Heart Fail
. 2024 Sep;
26(11):2453-2463.
PMID: 39282788
Aims: Benefits of mineralocorticoid receptor antagonists (MRAs) in heart failure with preserved and mildly reduced ejection fraction (HFpEF/HFmrEF) have not been established. Conventional randomized controlled trials are complex and expensive....
4.
Chandanabhumma P, Swaminathan S, Cabrera L, Hou H, Yang G, Kim K, et al.
J Mix Methods Res
. 2024 Aug;
18(3):235-246.
PMID: 39170802
While mixed methods research is increasingly used to examine determinants of unwarranted variability in healthcare delivery and outcomes, novel integrative approaches are required to meet the needs of mixed methods...
5.
Gondi K, Tam M, Chetcuti S, Pagani F, Grossman P, Deeb G, et al.
J Soc Cardiovasc Angiogr Interv
. 2024 Aug;
2(1):100530.
PMID: 39132542
Background: Aortic regurgitation (AR) is common and detrimental in patients with left ventricular assist devices (LVADs). Off-label use of transcatheter aortic valve replacement (TAVR) has emerged as a potential treatment...
6.
Aaronson K, Stewart G, Stevenson L, Richards B, Khalatbari S, Cascino T, et al.
JACC Heart Fail
. 2024 Jul;
12(10):1734-1746.
PMID: 38970587
Background: Left ventricular assist device (LVAD) use remains uncommon in advanced heart failure (HF) patients not dependent on inotropes. Objectives: Before considering a randomized trial comparing a strategy of earlier...
7.
Zhang Y, Golbus J, Wittrup E, Aaronson K, Najarian K
BMC Med Inform Decis Mak
. 2024 Feb;
24(1):53.
PMID: 38355512
Timely and accurate referral of end-stage heart failure patients for advanced therapies, including heart transplants and mechanical circulatory support, plays an important role in improving patient outcomes and saving costs....
8.
Sicim H, Noly P, Naik S, Sood V, Ohye R, Haft J, et al.
J Cardiothorac Surg
. 2024 Feb;
19(1):83.
PMID: 38336724
Background: Adult patients surviving with congenital heart disease (ACHD) is growing. We examine the factors associated with heart transplant outcomes in this challenging population with complex anatomy requiring redo-surgeries. Methods:...
9.
Thompson M, Hou H, Fliegner M, Guduguntla V, Cascino T, Aaronson K, et al.
J Cardiopulm Rehabil Prev
. 2024 Feb;
44(3):194-201.
PMID: 38300252
Purpose: Cardiac rehabilitation (CR) is an evidence-based, guideline-endorsed therapy for patients with heart failure with reduced ejection fraction (HFrEF) but is broadly underutilized. Identifying structural factors contributing to increased CR...
10.
Hammer Y, Xie J, Yang G, Bitar A, Haft J, Cascino T, et al.
J Heart Lung Transplant
. 2023 Dec;
43(4):604-614.
PMID: 38065237
Background: Gastrointestinal bleeding (GIB) results in frequent hospitalizations and impairs quality of life in durable left ventricular assist device (LVAD) recipients. Anticipation of these events before implantation could have important...